The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 56.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

18 Nov 2021 08:08

RNS Number : 8167S
British Smaller Companies VCT2 Plc
18 November 2021
 

British Smaller Companies VCT2 plc

Interim Management Statement

For the quarter ended 30 September 2021

British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 30 September 2021. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company's Total Return at 30 September 2021 was 138.2 pence per ordinary share, representing an increase of 3.2 pence per ordinary share over the Total Return of 135.0 pence per ordinary share as at 30 June 2021. The increase represents 5.0 per cent of the opening net asset value of 63.5 pence per ordinary share.

Cumulatively this takes the increase in the Total Return for the nine months to 30 September 2021 to 13.2 pence per share representing 24.0 per cent of the opening Net Asset Value (""NAV") of 55.0 pence per share.

In the quarter one new investment of £1.4 million was made into Vuealta, together with three follow-on investments totalling £0.3 million into Arraco, Ncam and Biz2Mobile. Vuealta delivers scenario planning and forecasting solutions for supply chain, finance and operations, with the investment enabling the business to continue its global expansion strategy and product development.

The Company completed the sale of its shareholding in Deep Secure in July. The exit generated capital proceeds of £3.3 million delivering a profit of £2.8 million above cost, and an uplift of £1.3 million on the carrying value at the beginning of the financial year. Including income, the total return from this investment was £3.8 million over an 11.6 year holding period, producing an internal rate of return of 23 per cent and a multiple of 7.7x cost.

In October 2021 the Company also completed the partial sale of 20 per cent of its holding in Matillion, generating capital proceeds of £5.9 million. The partial realisation, which was in line with the related valuation recognised at 30 September 2021, crystallised a profit on the partial realisation of £5.6 million above cost with the proceeds being equivalent to 3.3x the total investment of £1.8 million made by the Company into Matillion.

As a consequence of the above, on 7 October 2021 the directors announced the payment of a third interim dividend for the current year of 5.0 pence per ordinary share ("Third Interim Dividend"), which was paid on 16 November 2021 to shareholders on the register at the close of business on 15 October 2021. This brought total dividends paid in the current financial year to 8.0 pence per ordinary share. These cumulative dividends equate to a yield of 14.5 per cent of the NAV at 31 December 2020.

Your Company's portfolio has delivered a strong performance over the nine-month period to 30 September 2021, generating a return of £23.5 million. The cumulative increase in Total Return of 13.2 pence since the start of the year maintains the Total Return above the hurdle at which a performance fee becomes payable, provided that the Total Return is maintained through to 31 December 2021. As a result the Company has taken into account £4.1 million for a performance incentive (of which £0.8 million was recognised in the quarter). All returns are stated after taking into account the provision.

Performance

The movement in Total Return in pence per ordinary share is set out in the table below:

30 June 2021

Increase in Value

Buyback of shares

Movement

In Period

30 September 2021

Net Assets (£m)

89.0

4.5

(0.4)

4.1

93.1

NAV per share (PPS)

63.5p

3.2

-

3.2

66.7p

Cumulative dividends paid (PPS)

71.5p

-

-

-

71.5p

Total Return (PPS)

135.0p

3.2

-

3.2

138.2p

Shares in issue

140,231,049

-

(675,308)

(675,308)

139,555,741

The unaudited NAV per ordinary share increased from 63.5 pence per share to 66.7 pence per share, equivalent to 5.0 per cent in the period. Cumulative dividends paid at 30 September 2021 were 71.5 pence per ordinary share (30 June 2021: 71.5 pence per ordinary share).

The movements in NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 30 June 2021

89.0

63.5

Increase in portfolio value

5.6

4.0

Net operating costs

(0.3)

(0.2)

Incentive fee

(0.8)

(0.6)

Issue/buy-back of shares

(0.4)

-

4.1

3.2

NAV at 30 September 2021

93.1

66.7

 

Following payment of the second interim dividend of 1.5 pence per ordinary share for the year ending 31 December 2021 on 25 October 2021 and the third interim dividend of 5.0 pence per ordinary share on 16 November 2021 the unaudited net asset value is 60.2 pence per ordinary share.

Dividends and shares in issue

On 27 September 2021 the Company purchased 675,308 ordinary shares of 10 pence each at a price of 59.40 pence per ordinary share. These shares were placed in treasury.

The number of ordinary shares in issue at 30 September 2021 was 139,555,741 (30 June 2021: 140,231,049). In addition, at 30 September 2021 the Company held 15,276,543 ordinary shares in treasury (30 June 2021: 14,601,235).

Following the payment of the second interim dividend of 1.5 pence per ordinary share on 25 October 2021 the Company issued 760,733 ordinary shares under the DRIS, and following the payment of the third interim dividend of 5.0 pence per ordinary share on 16 November 2021 the Company issued 2,491,956 ordinary shares under the DRIS, taking cumulative dividends paid to 78.0 pence per ordinary share and the number of ordinary shares in issue to 142,808,430 at that date.

Net assets

Net assets at 30 September 2021 comprised the following:

£000

% of net assets

Unquoted investments at fair value

75,180

80.8%

Cash and cash equivalents

21,353

22.9%

Other net current liabilities

(3,449)

(3.7%)

Net assets

93,084

100.0%

 

Investments

The investment portfolio at 30 September 2021 comprised:

Valuation

£000

Cumulative valuation as a % of net assets

Matillion Limited

30,231

32.5%

Springboard Research Holdings Limited

4,124

36.9%

Intelligent Office UK

3,067

40.2%

Wooshii Limited

2,933

43.3%

KeTech Enterprises Limited

2,904

46.5%

Elucidat Ltd

2,791

49.5%

Unbiased EC1 Limited

2,786

52.5%

SharpCloud Software Limited

2,666

55.3%

Force24 Ltd

2,569

58.1%

ACC Aviation Group Limited

2,392

60.7%

56,463

60.7%

Other investments

18,717

20.1%

Total investments

75,180

80.8%

Investments made since November 2015 represented 78 per cent of the value of the unquoted portfolio at 30 September 2021.

Portfolio performance

Over the quarter to 30 September 2021 the aggregate portfolio valuation has increased by £5.6 million which incorporates a number of increased valuations including Matillion (£3.2 million) and Springboard (£1.3 million).

Fundraising

The Company launched a Joint Fundraising with British Smaller Companies VCT plc in the 2021/22 tax year on 22 September 2021, seeking to raise in aggregate £40 million, with an over-allotment facility of £20 million (the "Offers"). The Company announced on 11 October 2021 that the over-allotment facility would be utilised in relation to the Offers, and the Company is pleased to report that the Offers were fully utilised and that the Offers were closed to new applications on 12 November 2021. The Company anticipates that the first and final allotment in relation to the Offers will be made on or around 7 January 2022, with share certificates dispatched within 10 working days thereafter.

Outlook

Your Company is continuing to support those businesses in the portfolio that are investing for accelerated growth. This has been an increasing trend in the current year and one that is anticipated to continue through to 2022.

Whilst the pandemic and the new trading relationship with the EU have provided some uncertainty to the overall economic climate there remains a strong demand from the UK's smaller companies seeking to innovate their business models and management teams to drive further growth. The plans to add additional investment capacity are intended to ensure that your Company remains well funded to take advantage of the investment opportunities as they arise.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

18 November 2021

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTGZMMMRRVGMZG
Date   Source Headline
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.